{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:43:48Z","timestamp":1793691828172,"version":"4.5.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Municipal Science and Technology Major Project","award":["ZD2021CY001"],"award-info":[{"award-number":["ZD2021CY001"]}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"crossref","award":["20Z11901000"],"award-info":[{"award-number":["20Z11901000"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82172348"],"award-info":[{"award-number":["82172348"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Baoshan District Medical Science Construction Project","award":["BSZK-2023-A18"],"award-info":[{"award-number":["BSZK-2023-A18"]}]},{"name":"the constructing project of clinical key disciplines in Shanghai","award":["shslczdzk03302"],"award-info":[{"award-number":["shslczdzk03302"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-03754-6","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T07:36:36Z","timestamp":1740036996000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The virulence trait and genotype distribution amongst the Pseudomonas aeruginosa clinical strains"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiaohuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baishen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanlin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"issue":"6","key":"3754_CR1","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/j.1462-2920.2009.02041.x","volume":"12","author":"NJ Palleroni","year":"2010","unstructured":"Palleroni NJ. The Pseudomonas story. Environ Microbiol. 2010;12(6):1377\u201383. https:\/\/doi.org\/10.1111\/j.1462-2920.2009.02041.x.","journal-title":"Environ Microbiol"},{"key":"3754_CR2","doi-asserted-by":"publisher","unstructured":"Jurado-Mart\u00edn I, Sainz-Mej\u00edas M, McClean S. Pseudomonas aeruginosa: An Audacious Pathogen with an adaptable Arsenal of virulence factors. Int J Mol Sci. 2021;22(6). https:\/\/doi.org\/10.3390\/ijms22063128.","DOI":"10.3390\/ijms22063128"},{"issue":"1","key":"3754_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41392-022-01056-1","volume":"7","author":"S Qin","year":"2022","unstructured":"Qin S, Xiao W, Zhou C, Pu Q, Deng X, Lan L, et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct Target Therapy. 2022;7(1):199. https:\/\/doi.org\/10.1038\/s41392-022-01056-1.","journal-title":"Signal Transduct Target Therapy"},{"key":"3754_CR4","doi-asserted-by":"publisher","unstructured":"Daikos GL, da Cunha CA, Rossolini GM, Stone GG, Baillon-Plot N, Tawadrous M, et al. Review of Ceftazidime-Avibactam for the treatment of infections caused by Pseudomonas aeruginosa. Antibiot (Basel Switzerland). 2021;10(9). https:\/\/doi.org\/10.3390\/antibiotics10091126.","DOI":"10.3390\/antibiotics10091126"},{"issue":"3","key":"3754_CR5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/s1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318\u201327. https:\/\/doi.org\/10.1016\/s1473-3099(17)30753-3.","journal-title":"Lancet Infect Dis"},{"key":"3754_CR6","doi-asserted-by":"publisher","unstructured":"Elmassry MM, Colmer-Hamood JA, Kopel J, San Francisco MJ, Hamood AN. Anti-pseudomonas Aeruginosa vaccines and therapies: an Assessment of clinical trials. Microorganisms. 2023;11(4). https:\/\/doi.org\/10.3390\/microorganisms11040916.","DOI":"10.3390\/microorganisms11040916"},{"issue":"9","key":"3754_CR7","doi-asserted-by":"publisher","first-page":"e1009927","DOI":"10.1371\/journal.ppat.1009927","volume":"17","author":"S Bagayoko","year":"2021","unstructured":"Bagayoko S, Leon-Icaza SA, Pinilla M, Hessel A, Santoni K, P\u00e9ricat D, et al. Host phospholipid peroxidation fuels ExoU-dependent cell necrosis and supports Pseudomonas aeruginosa-driven pathology. PLoS Pathog. 2021;17(9):e1009927. https:\/\/doi.org\/10.1371\/journal.ppat.1009927.","journal-title":"PLoS Pathog"},{"issue":"6","key":"3754_CR8","doi-asserted-by":"publisher","first-page":"106450","DOI":"10.1016\/j.ijantimicag.2021.106450","volume":"58","author":"R Recio","year":"2021","unstructured":"Recio R, Viedma E, Gonz\u00e1lez-Bod\u00ed S, Villa J, Orellana M, Manche\u00f1o-Losa M, et al. Clinical and bacterial characteristics of Pseudomonas aeruginosa affecting the outcome of patients with bacteraemic pneumonia. Int J Antimicrob Agents. 2021;58(6):106450. https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106450.","journal-title":"Int J Antimicrob Agents"},{"key":"3754_CR9","doi-asserted-by":"publisher","unstructured":"de Sousa T, H\u00e9braud M, Dapkevicius M, Maltez L, Pereira JE, Capita R, et al. Genomic and metabolic characteristics of the pathogenicity in Pseudomonas aeruginosa. Int J Mol Sci. 2021;22(23). https:\/\/doi.org\/10.3390\/ijms222312892.","DOI":"10.3390\/ijms222312892"},{"key":"3754_CR10","doi-asserted-by":"publisher","unstructured":"Bogiel T, Depka D, Rzepka M, Kwieci\u0144ska-Pir\u00f3g J, Gospodarek-Komkowska E. Prevalence of the genes Associated with Biofilm and Toxins Synthesis amongst the Pseudomonas aeruginosa clinical strains. Antibiot (Basel Switzerland). 2021;10(3). https:\/\/doi.org\/10.3390\/antibiotics10030241.","DOI":"10.3390\/antibiotics10030241"},{"issue":"3","key":"3754_CR11","doi-asserted-by":"publisher","first-page":"e0038223","DOI":"10.1128\/jb.00382-23","volume":"206","author":"JR Mackinder","year":"2024","unstructured":"Mackinder JR, Hinkel LA, Schutz K, Eckstrom K, Fisher K, Wargo MJ. Sphingosine induction of the Pseudomonas aeruginosa hemolytic phospholipase C\/sphingomyelinase (PlcH). J Bacteriol. 2024;206(3):e0038223. https:\/\/doi.org\/10.1128\/jb.00382-23.","journal-title":"J Bacteriol"},{"issue":"8","key":"3754_CR12","doi-asserted-by":"publisher","first-page":"e1002206","DOI":"10.1371\/journal.ppat.1002206","volume":"7","author":"BW Bardoel","year":"2011","unstructured":"Bardoel BW, van der Ent S, Pel MJ, Tommassen J, Pieterse CM, van Kessel KP, et al. Pseudomonas evades immune recognition of flagellin in both mammals and plants. PLoS Pathog. 2011;7(8):e1002206. https:\/\/doi.org\/10.1371\/journal.ppat.1002206.","journal-title":"PLoS Pathog"},{"issue":"19","key":"3754_CR13","doi-asserted-by":"publisher","first-page":"5281","DOI":"10.1021\/bi702480t","volume":"47","author":"BT Greenhagen","year":"2008","unstructured":"Greenhagen BT, Shi K, Robinson H, Gamage S, Bera AK, Ladner JE, et al. Crystal structure of the pyocyanin biosynthetic protein PhzS. Biochemistry. 2008;47(19):5281\u20139. https:\/\/doi.org\/10.1021\/bi702480t.","journal-title":"Biochemistry"},{"issue":"12","key":"3754_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.molmed.2004.10.002","volume":"10","author":"GW Lau","year":"2004","unstructured":"Lau GW, Hassett DJ, Ran H, Kong F. The role of pyocyanin in Pseudomonas aeruginosa infection. Trends Mol Med. 2004;10(12):599\u2013606. https:\/\/doi.org\/10.1016\/j.molmed.2004.10.002.","journal-title":"Trends Mol Med"},{"issue":"2","key":"3754_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1021\/tx500259s","volume":"28","author":"S Sinha","year":"2015","unstructured":"Sinha S, Shen X, Gallazzi F, Li Q, Zmijewski JW, Lancaster JR Jr., et al. Generation of reactive oxygen species mediated by 1\u2013Hydroxyphenazine, a virulence factor of Pseudomonas aeruginosa. Chem Res Toxicol. 2015;28(2):175\u201381. https:\/\/doi.org\/10.1021\/tx500259s.","journal-title":"Chem Res Toxicol"},{"key":"3754_CR16","doi-asserted-by":"publisher","unstructured":"Silveira MC, Albano RM, Asensi MD, Carvalho-Assef AP. Description of genomic islands associated to the multidrug-resistant Pseudomonas aeruginosa clone ST277. Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2016;42:60\u20135; https:\/\/doi.org\/10.1016\/j.meegid.2016.04.024","DOI":"10.1016\/j.meegid.2016.04.024"},{"issue":"4","key":"3754_CR17","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1128\/iai.00621-09","volume":"78","author":"EM Harrison","year":"2010","unstructured":"Harrison EM, Carter ME, Luck S, Ou HY, He X, Deng Z, et al. Pathogenicity islands PAPI-1 and PAPI-2 contribute individually and synergistically to the virulence of Pseudomonas aeruginosa strain PA14. Infect Immun. 2010;78(4):1437\u201346. https:\/\/doi.org\/10.1128\/iai.00621-09.","journal-title":"Infect Immun"},{"issue":"3","key":"3754_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis. 2012;18(3):268\u201381. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x.","journal-title":"Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis"},{"issue":"1","key":"3754_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1128\/aac.50.1.43-48.2006","volume":"50","author":"V Aloush","year":"2006","unstructured":"Aloush V, Navon-Venezia S, Seigman-Igra Y, Cabili S, Carmeli Y. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother. 2006;50(1):43\u20138. https:\/\/doi.org\/10.1128\/aac.50.1.43-48.2006.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"3754_CR20","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1128\/cmr.00040-09","volume":"22","author":"PD Lister","year":"2009","unstructured":"Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev. 2009;22(4):582\u2013610. https:\/\/doi.org\/10.1128\/cmr.00040-09.","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"3754_CR21","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.resmic.2013.06.007","volume":"164","author":"SM Petit","year":"2013","unstructured":"Petit SM, Lavenir R, Colinon-Dupuich C, Boukerb AM, Cholley P, Bertrand X, et al. Lagooning of wastewaters favors dissemination of clinically relevant Pseudomonas aeruginosa. Res Microbiol. 2013;164(8):856\u201366. https:\/\/doi.org\/10.1016\/j.resmic.2013.06.007.","journal-title":"Res Microbiol"},{"issue":"1","key":"3754_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gks1039","volume":"41","author":"D Balasubramanian","year":"2013","unstructured":"Balasubramanian D, Schneper L, Kumari H, Mathee K. A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res. 2013;41(1):1\u201320. https:\/\/doi.org\/10.1093\/nar\/gks1039.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"3754_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/s0167-7012(00)00122-6","volume":"40","author":"S Stepanovic","year":"2000","unstructured":"Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods. 2000;40(2):175\u20139. https:\/\/doi.org\/10.1016\/s0167-7012(00)00122-6.","journal-title":"J Microbiol Methods"},{"key":"3754_CR24","doi-asserted-by":"publisher","unstructured":"Dave A, Samarth A, Karolia R, Sharma S, Karunakaran E, Partridge L, et al. Characterization of Ocular Clinical isolates of Pseudomonas aeruginosa from Non-contact Lens related keratitis patients from South India. Microorganisms. 2020;8(2). https:\/\/doi.org\/10.3390\/microorganisms8020260.","DOI":"10.3390\/microorganisms8020260"},{"issue":"5","key":"3754_CR25","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.21037\/jtd.2018.04.86","volume":"10","author":"M Ju","year":"2018","unstructured":"Ju M, Hou D, Chen S, Wang Y, Tang X, Liu J, et al. Risk factors for mortality in ICU patients with Acinetobacter baumannii ventilator-associated pneumonia: impact of bacterial cytotoxicity. J Thorac Disease. 2018;10(5):2608\u201317. https:\/\/doi.org\/10.21037\/jtd.2018.04.86.","journal-title":"J Thorac Disease"},{"key":"3754_CR26","doi-asserted-by":"publisher","unstructured":"Wood SJ, Goldufsky JW, Seu MY, Dorafshar AH, Shafikhani SH. Pseudomonas aeruginosa Cytotoxins: mechanisms of cytotoxicity and impact on inflammatory responses. Cells. 2023;12(1). https:\/\/doi.org\/10.3390\/cells12010195.","DOI":"10.3390\/cells12010195"},{"key":"3754_CR27","doi-asserted-by":"publisher","first-page":"926758","DOI":"10.3389\/fcimb.2022.926758","volume":"12","author":"C Liao","year":"2022","unstructured":"Liao C, Huang X, Wang Q, Yao D, Lu W. Virulence factors of Pseudomonas Aeruginosa and Antivirulence strategies to Combat its Drug Resistance. Front Cell Infect Microbiol. 2022;12:926758. https:\/\/doi.org\/10.3389\/fcimb.2022.926758.","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"3754_CR28","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1093\/gbe\/evx243","volume":"9","author":"T Miyoshi-Akiyama","year":"2017","unstructured":"Miyoshi-Akiyama T, Tada T, Ohmagari N, Viet Hung N, Tharavichitkul P, Pokhrel BM, et al. Emergence and spread of Epidemic Multidrug-Resistant Pseudomonas aeruginosa. Genome Biol Evol. 2017;9(12):3238\u201345. https:\/\/doi.org\/10.1093\/gbe\/evx243.","journal-title":"Genome Biol Evol"},{"issue":"4","key":"3754_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cmi.2023.12.026","volume":"30","author":"A Oliver","year":"2024","unstructured":"Oliver A, Rojo-Molinero E, Arca-Suarez J, Be\u015fli Y, Bogaerts P, Cant\u00f3n R, et al. Pseudomonasaeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID\/ISARPAE Group. Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis. 2024;30(4):469\u201380. https:\/\/doi.org\/10.1016\/j.cmi.2023.12.026.","journal-title":"Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis"},{"key":"3754_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.micpath.2017.12.052","volume":"115","author":"F Haghi","year":"2018","unstructured":"Haghi F, Zeighami H, Monazami A, Toutouchi F, Nazaralian S, Naderi G. Diversity of virulence genes in multidrug resistant Pseudomonas aeruginosa isolated from burn wound infections. Microb Pathog. 2018;115:251\u20136. https:\/\/doi.org\/10.1016\/j.micpath.2017.12.052.","journal-title":"Microb Pathog"},{"key":"3754_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2147\/idr.S346313","volume":"15","author":"Y Park","year":"2022","unstructured":"Park Y, Koo SH, Epidemiology. Molecular characteristics, and virulence factors of Carbapenem-Resistant Pseudomonas aeruginosa isolated from patients with urinary tract infections. Infect drug Resist. 2022;15:141\u201351. https:\/\/doi.org\/10.2147\/idr.S346313.","journal-title":"Infect drug Resist"},{"key":"3754_CR32","doi-asserted-by":"publisher","unstructured":"Zhu JM, Jiang RJ, Wu JL, Weng XB, Ling LP. Antibiotic resistance determinants and virulence factors of Hypervirulent and Carbapenem Non-susceptible Pseudomonas aeruginosa. Clin Lab. 2022;68(4). https:\/\/doi.org\/10.7754\/Clin.Lab.2021.210801.","DOI":"10.7754\/Clin.Lab.2021.210801"},{"issue":"5","key":"3754_CR33","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.gendis.2022.09.009","volume":"10","author":"X Shao","year":"2023","unstructured":"Shao X, Yao C, Ding Y, Hu H, Qian G, He M, et al. The transcriptional regulators of virulence for Pseudomonas aeruginosa: therapeutic opportunity and preventive potential of its clinical infections. Genes Dis. 2023;10(5):2049\u201363. https:\/\/doi.org\/10.1016\/j.gendis.2022.09.009.","journal-title":"Genes Dis"},{"key":"3754_CR34","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez-Jim\u00e9nez A, Llamas MA, Marcos-Torres FJ. Transcriptional regulators Controlling Virulence in Pseudomonas aeruginosa. Int J Mol Sci. 2023;24(15). https:\/\/doi.org\/10.3390\/ijms241511895.","DOI":"10.3390\/ijms241511895"},{"issue":"8","key":"3754_CR35","doi-asserted-by":"publisher","first-page":"e42973","DOI":"10.1371\/journal.pone.0042973","volume":"7","author":"M Agnello","year":"2012","unstructured":"Agnello M, Wong-Beringer A. Differentiation in quinolone resistance by virulence genotype in Pseudomonas aeruginosa. PLoS ONE. 2012;7(8):e42973. https:\/\/doi.org\/10.1371\/journal.pone.0042973.","journal-title":"PLoS ONE"},{"key":"3754_CR36","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2147\/idr.S233694","volume":"13","author":"NA Hassuna","year":"2020","unstructured":"Hassuna NA, Mandour SA, Mohamed ES. Virulence constitution of Multi-drug-resistant Pseudomonas aeruginosa in Upper Egypt. Infect drug Resist. 2020;13:587\u201395. https:\/\/doi.org\/10.2147\/idr.S233694.","journal-title":"Infect drug Resist"},{"key":"3754_CR37","doi-asserted-by":"publisher","unstructured":"Camus L, Vandenesch F, Moreau K. From genotype to phenotype: adaptations of Pseudomonas aeruginosa to the cystic fibrosis environment. Microb Genomics. 2021;7(3). https:\/\/doi.org\/10.1099\/mgen.0.000513.","DOI":"10.1099\/mgen.0.000513"},{"key":"3754_CR38","doi-asserted-by":"publisher","unstructured":"Recio R, Manche\u00f1o M, Viedma E, Villa J, Orellana M, Lora-Tamayo J, et al. Predictors of Mortality in Bloodstream infections caused by Pseudomonas aeruginosa and Impact of Antimicrobial Resistance and bacterial virulence. Antimicrob Agents Chemother. 2020;64(2). https:\/\/doi.org\/10.1128\/aac.01759-19.","DOI":"10.1128\/aac.01759-19"},{"issue":"1","key":"3754_CR39","doi-asserted-by":"publisher","first-page":"14208","DOI":"10.1038\/s41598-023-41333-9","volume":"13","author":"A Llanos","year":"2023","unstructured":"Llanos A, Achard P, Bousquet J, Lozano C, Zalacain M, Sable C, et al. Higher levels of Pseudomonas aeruginosa LasB elastase expression are associated with early-stage infection in cystic fibrosis patients. Sci Rep. 2023;13(1):14208. https:\/\/doi.org\/10.1038\/s41598-023-41333-9.","journal-title":"Sci Rep"},{"key":"3754_CR40","doi-asserted-by":"publisher","unstructured":"Bogiel T, Depka D, Kruszewski S, Rutkowska A, Kanarek P, Rzepka M, et al. Comparison of virulence-factor-encoding genes and genotype distribution amongst clinical Pseudomonas aeruginosa strains. Int J Mol Sci. 2023;24(2). https:\/\/doi.org\/10.3390\/ijms24021269.","DOI":"10.3390\/ijms24021269"},{"issue":"3","key":"3754_CR41","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3906\/sag-1406-58","volume":"45","author":"FI Sonbol","year":"2015","unstructured":"Sonbol FI, Khalil MA, Mohamed AB, Ali SS. Correlation between antibiotic resistance and virulence of Pseudomonas aeruginosa clinical isolates. Turk J Med Sci. 2015;45(3):568\u201377. https:\/\/doi.org\/10.3906\/sag-1406-58.","journal-title":"Turk J Med Sci"},{"key":"3754_CR42","doi-asserted-by":"publisher","unstructured":"Vaillancourt M, Limsuwannarot SP, Bresee C, Poopalarajah R, Jorth P. Pseudomonas aeruginosa mexR and mexEF Antibiotic Efflux pump variants exhibit increased virulence. Antibiot (Basel Switzerland). 2021;10(10). https:\/\/doi.org\/10.3390\/antibiotics10101164.","DOI":"10.3390\/antibiotics10101164"},{"issue":"9","key":"3754_CR43","doi-asserted-by":"publisher","first-page":"e665","DOI":"10.1016\/s2666-5247(23)00113-1","volume":"4","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Jia P, Yu W, Chu X, Liu X, Yang Q. The epidemiology and virulence of carbapenem-resistant Pseudomonas aeruginosa in China. Lancet Microbe. 2023;4(9):e665. https:\/\/doi.org\/10.1016\/s2666-5247(23)00113-1.","journal-title":"Lancet Microbe"},{"key":"3754_CR44","doi-asserted-by":"publisher","first-page":"975616","DOI":"10.3389\/fmicb.2022.975616","volume":"13","author":"P Behzadi","year":"2022","unstructured":"Behzadi P, Ambrosi C, Scribano D, Zanetti S, Sarshar M, Gajd\u00e1cs M, et al. Editorial: current perspectives on Pseudomonas aeruginosa: epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens. Front Microbiol. 2022;13:975616. https:\/\/doi.org\/10.3389\/fmicb.2022.975616.","journal-title":"Front Microbiol"},{"issue":"2","key":"3754_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jamaophthalmol.2013.778","volume":"131","author":"DS Borkar","year":"2013","unstructured":"Borkar DS, Fleiszig SM, Leong C, Lalitha P, Srinivasan M, Ghanekar AA, et al. Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis. JAMA Ophthalmol. 2013;131(2):147\u201353. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.778.","journal-title":"JAMA Ophthalmol"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03754-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-03754-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03754-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T07:36:52Z","timestamp":1740037012000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-03754-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3754"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-03754-6","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethic statement was approved by the Ethics Committee at Zhongshan Hospital Affiliated to Fudan University (B2022-044R) (Approved on 25 February 2022), and informed consent was acquired for clinical and biological information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}